CRP and bronchiectasis: Gu et al. discovered that a rise of CA125 in bronchiectasis patients declined after anti-inflammation therapy and CRP and TNF-α were independent indicators for the elevated CA125 in bronchiectasis patients [15], indicating the potential relationship between inflammation and elevated STMs.